Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio A Emini

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Expert Review of Vaccines|August 3, 2004
AIDS vaccinesEmilio A Emini, David B Weiner
Annual Review of Medicine|January 30, 2004
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectorsJohn W Shiver, Emilio A Emini
Science (New York, N.Y.)|June 26, 2004
AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hopeEmilio A Emini, Wayne C Koff
Annals of the New York Academy of Sciences|July 27, 2012
Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccineWilliam C Gruber, Daniel A Scott, Emilio A Emini
Annual Review of Medicine|January 31, 2002
Potential new therapies for the treatment of HIV-1 infectionJon H Condra, Michael D Miller, Daria J Hazuda, et al.
Vaccine|September 6, 2002
Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in miceXaioping Liang, Tong-Ming Fu, Hong Xie, et al.
Vaccine|August 27, 2013
Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countriesAllison Thompson, Alejandra Gurtman, Scott Patterson, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|August 14, 2013
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in MexicoMaricruz Gutiérrez Brito, Allison Thompson, Douglas Girgenti, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2008
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034)Mike Flint, Stanley Mullen, Anne M Deatly, et al.
The Pediatric Infectious Disease Journal|September 25, 2012
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trialRosalyn Singleton, Jay Wenger, Joseph A Klejka, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Expert Review of Vaccines|August 3, 2004
AIDS vaccinesEmilio A Emini, David B Weiner
Annual Review of Medicine|January 30, 2004
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectorsJohn W Shiver, Emilio A Emini
Science (New York, N.Y.)|June 26, 2004
AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hopeEmilio A Emini, Wayne C Koff
Annals of the New York Academy of Sciences|July 27, 2012
Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccineWilliam C Gruber, Daniel A Scott, Emilio A Emini
Annual Review of Medicine|January 31, 2002
Potential new therapies for the treatment of HIV-1 infectionJon H Condra, Michael D Miller, Daria J Hazuda, et al.
Vaccine|September 6, 2002
Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in miceXaioping Liang, Tong-Ming Fu, Hong Xie, et al.
Vaccine|August 27, 2013
Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countriesAllison Thompson, Alejandra Gurtman, Scott Patterson, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|August 14, 2013
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in MexicoMaricruz Gutiérrez Brito, Allison Thompson, Douglas Girgenti, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2008
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034)Mike Flint, Stanley Mullen, Anne M Deatly, et al.
The Pediatric Infectious Disease Journal|September 25, 2012
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trialRosalyn Singleton, Jay Wenger, Joseph A Klejka, et al.
Pageof 9